Chokshi S - Search Results

1

Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.

Cherubini A, Ostadreza M, Jamialahmadi O, Pelusi S, Rrapaj E, Casirati E, Passignani G, Norouziesfahani M, Sinopoli E, Baselli G, Meda C, Dongiovanni P, Dondossola D, Youngson N, Tourna A, Chokshi S, Bugianesi E; EPIDEMIC Study Investigators; Della Torre S, Prati D, Romeo S, Valenti L. Cherubini A, et al. Among authors: chokshi s. Nat Med. 2023 Oct;29(10):2643-2655. doi: 10.1038/s41591-023-02553-8. Epub 2023 Sep 25. Nat Med. 2023. PMID: 37749332 Free PMC article.

2

Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions.

Pachiadakis I, Chokshi S, Cooksley H, Farmakiotis D, Sarrazin C, Zeuzem S, Michalak TI, Naoumov NV. Pachiadakis I, et al. Among authors: chokshi s. Clin Immunol. 2009 Jun;131(3):415-25. doi: 10.1016/j.clim.2009.02.001. Epub 2009 Mar 20. Clin Immunol. 2009. PMID: 19303818

3

Genomic variations in the hepatitis B core gene: a possible factor influencing response to interferon alfa treatment.

Naoumov NV, Thomas MG, Mason AL, Chokshi S, Bodicky CJ, Farzaneh F, Williams R, Perrillo RP. Naoumov NV, et al. Among authors: chokshi s. Gastroenterology. 1995 Feb;108(2):505-14. doi: 10.1016/0016-5085(95)90080-2. Gastroenterology. 1995. PMID: 7835593

4

Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.

Coombes JD, Choi SS, Swiderska-Syn M, Manka P, Reid DT, Palma E, Briones-Orta MA, Xie G, Younis R, Kitamura N, Della Peruta M, Bitencourt S, Dollé L, Oo YH, Mi Z, Kuo PC, Williams R, Chokshi S, Canbay A, Claridge LC, Eksteen B, Diehl AM, Syn WK. Coombes JD, et al. Among authors: chokshi s. Biochim Biophys Acta. 2016 Jan;1862(1):135-44. doi: 10.1016/j.bbadis.2015.10.028. Epub 2015 Oct 31. Biochim Biophys Acta. 2016. PMID: 26529285 Free PMC article.

5

APOBEC and iNOS are not the main intracellular effectors of IFN-gamma-mediated inactivation of Hepatitis B virus replication.

Proto S, Taylor JA, Chokshi S, Navaratnam N, Naoumov NV. Proto S, et al. Among authors: chokshi s. Antiviral Res. 2008 Jun;78(3):260-7. doi: 10.1016/j.antiviral.2008.01.006. Epub 2008 Feb 8. Antiviral Res. 2008. PMID: 18313151

6

Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study.

Guobuzaite A, Chokshi S, Balciūniene L, Voinic A, Stikleryte A, Zagminas K, Ambrozaitis A, Naoumov N. Guobuzaite A, et al. Among authors: chokshi s. Medicina (Kaunas). 2008;44(7):510-20. Medicina (Kaunas). 2008. PMID: 18695347 Free article.

7

Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.

Evans A, Riva A, Cooksley H, Phillips S, Puranik S, Nathwani A, Brett S, Chokshi S, Naoumov NV. Evans A, et al. Among authors: chokshi s. Hepatology. 2008 Sep;48(3):759-69. doi: 10.1002/hep.22419. Hepatology. 2008. PMID: 18697210

8

Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy.

Tang KH, Herrmann E, Cooksley H, Tatman N, Chokshi S, Williams R, Zeuzem S, Naoumov NV. Tang KH, et al. Among authors: chokshi s. J Hepatol. 2005 Nov;43(5):776-82. doi: 10.1016/j.jhep.2005.05.024. Epub 2005 Jun 28. J Hepatol. 2005. PMID: 16139918

9

The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call.

Tedder RS, Rodger AJ, Fries L, Ijaz S, Thursz M, Rosenberg W, Naoumov N, Banatvala J, Williams R, Dusheiko G, Chokshi S, Wong T, Rosenberg G, Moreea S, Bassendine M, Jacobs M, Mills PR, Mutimer D, Ryder SD, Bathgate A, Hussaini H, Dillon JF, Wright M, Bird G, Collier J, Anderson M, Johnson AM; Collaborative UK Study of Chronic Hepatitis B Infection (CUSHI-B) Study Group. Tedder RS, et al. Among authors: chokshi s. Clin Infect Dis. 2013 Apr;56(7):951-60. doi: 10.1093/cid/cis1013. Epub 2012 Dec 7. Clin Infect Dis. 2013. PMID: 23223601

10

Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis.

Hull DN, Cooksley H, Chokshi S, Williams RO, Abraham S, Taylor PC. Hull DN, et al. Among authors: chokshi s. Arthritis Res Ther. 2016 Dec 23;18(1):303. doi: 10.1186/s13075-016-1197-5. Arthritis Res Ther. 2016. PMID: 28010726 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142 results

Search Page